adverse effects of glp 1 GI Glucagon-Like Peptide-1 Receptor Agonists A Retrospective Comparative Analysis of

- While the trial met its primary endpoint, 11.9% discontinued due to GI-related AEs, and three reversible Grade 3 liver enzyme elevations were observed

especially in weight-bearing joints like the knees and hips

There may be similar brand-name drugs available that the insurance company can cover at a lower cost

Diabetes Care 45(Suppl 1):S17S38

One day after winning approval of colorectal cancer drug Fruzaqla, the Japanese pharma announced the FDA approval of Adzynma for congenital thrombotic thrombocytopenic purpura (cTTP)

Active management through dietary changes , probiotics, and the other strategies in this guide can significantly accelerate improvement